Alvogen Group
Alvogen is a privately-owned specialty pharmaceutical company based in Kópavogur, Iceland, with additional offices in the United States, South Korea, and Romania. Established in 2010, Alvogen focuses on the development, manufacturing, and marketing of generic pharmaceuticals, biosimilar products, and over-the-counter (OTC) medicines. The company's product portfolio includes a wide range of therapeutic solutions for oncology, cardiology, respiratory medicine, neurology, and gastroenterology, aimed at providing affordable medications to improve patient health. Alvogen also engages in contract manufacturing and contract research, further expanding its capabilities in the pharmaceutical market while striving to reduce healthcare costs globally.
Alvotech is a biopharmaceutical company that specializes in the development and manufacture of biosimilar medicines aimed at treating severe and chronic conditions. Founded in 2013 and headquartered in Reykjavík, Iceland, with additional facilities in Germany and Switzerland, Alvotech focuses on creating biosimilar versions of leading monoclonal antibodies. The company has six key biosimilar molecules in its development pipeline and has invested over $500 million in this endeavor. Alvotech aims to enhance patient access to effective treatments and improve the overall quality of life for individuals facing various health challenges. In pursuit of its goals, Alvotech has established strategic partnerships with prominent global pharmaceutical companies to facilitate the commercialization of its products.
Kerecis is developing the Kerecis Omega3 fish skin graft technology for use in products to treat chronic wounds, for hernia repair, breast reconstruction and abdominal wall reconstruction. their patented acellular fish skin material improves upon current human and porcine technologies through improved economics and clinical performance, reduced disease transfer risk and absence of cultural constraints on usage.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.